Noninvasive Imaging for Supporting Basic Research

Imaging has long been indispensable in clinical practice. Increasingly, in vivo imaging of small laboratory animals (i.e., mice and rats) has emerged as a critical component of preclinical biomedical research as well (Beckman et al. 2007; Cherry 2006; Gross and Piwnica-Worms 2006; Pomper 2005). Small-animal imaging provides a noninvasive means of assaying biological structure and function in vivo, yielding quantitative, spatially and temporally indexed information on normal and diseased tissues such as tumors. Importantly, because of its noninvasive nature, imaging allows serial (i.e., longitudinal) assay of rodent models of human cancer and cardiovascular, neurological, and other diseases over the entire natural history of the disease process, from inception to progression, and monitoring of the effectiveness of treatment or other interventions (with each animal serving as its own control and thereby reducing biological variability). This also serves to minimize the number of experimental animals required for a particular study. With the ongoing development of genetically engineered (i.e., transgenic and knock out) rodent models of cancer and other critical diseases (Malakoff 2000), such models are increasingly more realistic in recapitulating the natural history and clinical sequelae of the corresponding human disease and the ability to track these disease models long-term is therefore invaluable. Importantly, in contrast to cell or tissue culture-based experiments, studies in intact animals incorporate all of the interacting physiological factors – neuronal, hormonal, nutritional, immunological, etc. – present in the complex in vivo milieu. Intact whole-animal models also facilitate investigation of systemic aspects of disease such as cancer metastasis, which are difficult or impossible to replicate in ex vivo systems. Further, because many of the same imaging modalities – magnetic resonance imaging and spectroscopic imaging (MRI and MRSI), positron emission tomography (PET), single-photon emission computed tomography (SPECT), transmission computed tomography (CT), and ultrasound (US) – used in the clinic are also used in the laboratory setting, the findings of small-animal imaging are readily translatable to patients.

[1]  E. Wisner,et al.  A Surface-Modified Chylomicron Remnant-like Emulsion for Percutaneous Computed Tomography Lymphography: Synthesis and Preliminary Imaging Findings , 2002, Investigative radiology.

[2]  S R Cherry,et al.  Optical imaging of Cerenkov light generation from positron-emitting radiotracers , 2009, Physics in medicine and biology.

[3]  S. Cherry,et al.  Combining anatomy and function: the path to true image fusion , 2001, European Radiology.

[4]  Martin G Pomper,et al.  Translational molecular imaging for cancer , 2005, Cancer imaging : the official publication of the International Cancer Imaging Society.

[5]  R. Blasberg,et al.  Molecular imaging: reporter gene imaging. , 2008, Handbook of experimental pharmacology.

[6]  Ronald G Blasberg,et al.  Multimodality in vivo molecular-genetic imaging. , 2004, Bioconjugate chemistry.

[7]  C. Brennan,et al.  A Brain Tumor Molecular Imaging Strategy Using A New Triple-Modality MRI-Photoacoustic-Raman Nanoparticle , 2011, Nature Medicine.

[8]  Pat Zanzonico,et al.  Positron emission tomography: a review of basic principles, scanner design and performance, and current systems. , 2004, Seminars in nuclear medicine.

[9]  S. Cherry The 2006 Henry N. Wagner Lecture: Of mice and men (and positrons)--advances in PET imaging technology. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  David K. Stevenson,et al.  Bioluminescent indicators in living mammals , 1998, Nature Medicine.

[11]  Bernd J Pichler,et al.  Combined PET/MRI: one step further in multimodality imaging. , 2010, Trends in molecular medicine.

[12]  D W Townsend,et al.  A combined PET/CT scanner: the choices. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  S. Larson,et al.  Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15 , 2003, Nature Medicine.

[14]  Armin Kolb,et al.  Positron emission tomography/magnetic resonance imaging: the next generation of multimodality imaging? , 2008, Seminars in nuclear medicine.

[15]  P. Grzelak,et al.  Assessment of clinical usefulness of 131I alpha-methyl-tyrosine and fused SPECT/MRI imaging for diagnostics of recurrent cerebral gliomas. , 2004, Nuclear medicine review. Central & Eastern Europe.

[16]  Jan Grimm,et al.  Intraoperative Imaging of Positron Emission Tomographic Radiotracers Using Cerenkov Luminescence Emissions , 2011 .

[17]  Robert A Kruger,et al.  Thermoacoustic computed tomography using a conventional linear transducer array. , 2003, Medical physics.

[18]  Erin Jackson,et al.  Cerenkov Radiation Energy Transfer (CRET) Imaging: A Novel Method for Optical Imaging of PET Isotopes in Biological Systems , 2010, PloS one.

[19]  Michel Sadelain,et al.  Targeted elimination of prostate cancer by genetically directed human T lymphocytes. , 2005, Cancer research.

[20]  J. Bushberg The Essential Physics of Medical Imaging , 2001 .

[21]  R. Blasberg,et al.  Human reporter genes: potential use in clinical studies. , 2007, Nuclear medicine and biology.

[22]  Jan Grimm,et al.  Cerenkov Luminescence Imaging of Medical Isotopes , 2010, Journal of Nuclear Medicine.

[23]  R. Blasberg,et al.  Reporter gene imaging: potential impact on therapy. , 2005, Nuclear medicine and biology.

[24]  R. Weissleder,et al.  Fluorescence molecular tomography resolves protease activity in vivo , 2002, Nature Medicine.

[25]  S. Vallabhajosula Molecular Imaging: Radiopharmaceuticals for PET and SPECT , 2009 .

[26]  Neal Rosen,et al.  Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors , 2004, Nature Biotechnology.

[27]  Vasilis Ntziachristos,et al.  Translational optical imaging. , 2012, AJR. American journal of roentgenology.

[28]  Ciprian Catana,et al.  Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET/MRI. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  Ciprian Catana,et al.  Simultaneous PET-MRI: a new approach for functional and morphological imaging , 2008, Nature Medicine.

[30]  G. Scagliotti,et al.  Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  Michel Sadelain,et al.  Targeting tumours with genetically enhanced T lymphocytes , 2003, Nature Reviews Cancer.

[32]  K.C.P. Li Molecular imaging II , 2004, IEEE Engineering in Medicine and Biology Magazine.

[33]  Pat Zanzonico,et al.  Principles of Nuclear Medicine Imaging: Planar, SPECT, PET, Multi-modality, and Autoradiography Systems , 2012, Radiation research.

[34]  Hans-Ulrich Gremlich,et al.  In Vivo mouse imaging and spectroscopy in drug discovery , 2007, NMR in biomedicine.

[35]  Andreas H. Jacobs,et al.  Imaging in Neurology Research I: Neurooncology , 2011 .

[36]  Jonathan R. Lindner,et al.  Microbubbles in medical imaging: current applications and future directions , 2004, Nature Reviews Drug Discovery.

[37]  Sanjiv S. Gambhir,et al.  Molecular Optical Imaging with Radioactive Probes , 2010, PloS one.

[38]  C. Ling,et al.  Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia. , 2009, Neoplasia.

[39]  Vasilis Ntziachristos,et al.  Looking and listening to light: the evolution of whole-body photonic imaging , 2005, Nature Biotechnology.

[40]  Simon R Cherry,et al.  Small-animal preclinical nuclear medicine instrumentation and methodology. , 2008, Seminars in nuclear medicine.

[41]  J. Théberge,et al.  A comparison of MR-based attenuation correction in PET versus SPECT , 2011, Physics in medicine and biology.

[43]  J. Fujimoto,et al.  Optical Coherence Tomography , 1991 .

[44]  Timothy J. Hoffman,et al.  Non-invasive MicroCT Imaging Characterization and In Vivo Targeting of BB2 Receptor Expression of a PC-3 Bone Metastasis Model , 2012, Molecular Imaging and Biology.

[45]  S. Larson,et al.  Early tumor response to Hsp90 therapy using HER2 PET: comparison with 18F-FDG PET. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[46]  M G Pomper,et al.  Molecular imaging: an overview. , 2001, Academic radiology.

[47]  Giovanni Lucignani,et al.  Čerenkov radioactive optical imaging: a promising new strategy , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[48]  D. Piwnica-Worms,et al.  Molecular imaging strategies for drug discovery and development. , 2006, Current opinion in chemical biology.

[49]  D Malakoff,et al.  The Rise of the Mouse, Biomedicine's Model Mammal , 2000, Science.

[50]  J. Humm,et al.  Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of colorectal cancer metastatic to liver. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[51]  V. Sossi,et al.  Technical performance evaluation of a human brain PET/MRI system , 2012, European Radiology.

[52]  John L. Humm,et al.  Quantitative Modeling of Cerenkov Light Production Efficiency from Medical Radionuclides , 2012, PloS one.

[53]  Simon R. Cherry,et al.  Quantitative, Simultaneous PET/MRI for Intratumoral Imaging with an MRI-Compatible PET Scanner , 2012, The Journal of Nuclear Medicine.

[54]  M J Welch,et al.  Small animal imaging: current technology and perspectives for oncological imaging , 2002 .

[55]  Bernd J. Pichler,et al.  Small animal imaging : basics and practical guide , 2011 .

[56]  Sanjiv S Gambhir,et al.  Raman's “Effect” on Molecular Imaging , 2011, The Journal of Nuclear Medicine.

[57]  David W Townsend,et al.  Positron emission tomography/computed tomography. , 2008, Seminars in nuclear medicine.

[58]  Da Xing,et al.  Photoacoustic imaging with deconvolution algorithm. , 2004, Physics in medicine and biology.

[59]  Pat Zanzonico,et al.  Introduction to Clinical and Laboratory (Small-Animal) Image Registration and Fusion , 2006, 2006 International Conference of the IEEE Engineering in Medicine and Biology Society.

[60]  Jan Grimm,et al.  Positron Lymphography: Multimodal, High-Resolution, Dynamic Mapping and Resection of Lymph Nodes After Intradermal Injection of 18F-FDG , 2012, The Journal of Nuclear Medicine.

[61]  Thomas Beyer,et al.  A combined PET/CT scanner: the path to true image fusion. , 2002, The British journal of radiology.

[62]  Jacob Willig-Onwuachi,et al.  Studies of the interactions of an MRI system with the shielding in a combined PET/MRI scanner , 2010, Physics in medicine and biology.

[63]  Simon R Cherry,et al.  Cerenkov luminescence tomography for small-animal imaging. , 2010, Optics letters.

[64]  Thomas Beyer,et al.  PET/CT scanners: a hardware approach to image fusion. , 2003, Seminars in nuclear medicine.

[65]  B. Schölkopf,et al.  Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[66]  Vasilis Ntziachristos,et al.  Optical imaging of cancer heterogeneity with multispectral optoacoustic tomography. , 2012, Radiology.

[67]  Matthias Hofmann,et al.  Hybrid PET/MRI of Intracranial Masses: Initial Experiences and Comparison to PET/CT , 2010, The Journal of Nuclear Medicine.

[68]  E. Russell Ritenour,et al.  Principles and Advanced Methods in Medical Imaging and Image Analysis , 2008, American Journal of Neuroradiology.

[69]  David A Mankoff,et al.  A definition of molecular imaging. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[70]  Jean Théberge,et al.  Variable Lung Density Consideration in Attenuation Correction of Whole-Body PET/MRI , 2012, The Journal of Nuclear Medicine.

[71]  Pat Zanzonico Multimodality Image Registration and Fusion , 2008 .

[72]  R. Blasberg,et al.  Multi-modality molecular imaging of tumors. , 2006, Hematology/oncology clinics of North America.

[73]  S. Heller,et al.  Physics, Instrumentation, and Radiation Protection , 2007 .

[74]  S. Cherry In-Vivo Whole-Body Imaging of the Laboratory Mouse , 2007 .

[75]  Andreas H Hielscher,et al.  Optical tomographic imaging of small animals. , 2005, Current opinion in biotechnology.

[76]  W. J. Lorenz,et al.  Pharmacokinetic Mapping of the Breast: A New Method for Dynamic MR Mammography , 1995, Magnetic resonance in medicine.